Helena Aebersold
Overview
Explore the profile of Helena Aebersold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aebersold H, Foster-Witassek F, Amberg S, Serra-Burriel M, Moschovitis G, Zannoni R, et al.
Swiss Med Wkly
. 2025 Jan;
155():3669.
PMID: 39878030
Aims: We aimed to explore atrial fibrillation (AF)-induced productivity losses in working-age atrial fibrillation patients and to estimate atrial fibrillation-related indirect costs. Methods: Between 2014 and 2017, the Swiss Atrial...
2.
Stauber A, Muller A, Rommers N, Aeschbacher S, Bonati L, Conen D, et al.
Heart Rhythm
. 2024 Aug;
22(1):6-12.
PMID: 39177518
Background: Electrical cardioversion (ECV) is frequently performed in symptomatic atrial fibrillation. Objective: This study aimed to assess the association of ECV with infarcts on brain magnetic resonance imaging (bMRI) and...
3.
Aebersold H, Foster-Witassek F, Aeschbacher S, Beer J, Blozik E, Blum M, et al.
Open Heart
. 2024 Feb;
11(1).
PMID: 38302139
Aims: Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrial fibrillation (AF) patients. However, evidence on the real-world...
4.
Foster-Witassek F, Aebersold H, Aeschbacher S, Ammann P, Beer J, Blozik E, et al.
J Am Heart Assoc
. 2023 Nov;
12(21):e031872.
PMID: 37929709
Background Optimizing health-related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long-term HRQoL trajectories and the impact of patient and...
5.
Serra-Burriel M, Aebersold H, Foster-Witassek F, Coslovsky M, Rodondi N, Blum M, et al.
Value Health
. 2023 Sep;
26(12):1721-1729.
PMID: 37741443
Objectives: Randomized controlled trials of pulmonary vein isolation (PVI) for treating atrial fibrillation (AF) have proven the procedure's efficacy. Studies assessing its empirical cost-effectiveness outside randomized trial settings are lacking....
6.
Aebersold H, Foster-Witassek F, Serra-Burriel M, Brungger B, Aeschbacher S, Beer J, et al.
BMJ Open
. 2023 Sep;
13(9):e072080.
PMID: 37709325
Aims: Atrial fibrillation (AF) costs are expected to be substantial, but cost comparisons with the general population are scarce. Using data from the prospective Swiss-AF cohort study and population-based controls,...
7.
Aebersold H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, Aeschbacher S, Auricchio A, et al.
Heart
. 2022 Nov;
109(10):763-770.
PMID: 36332981
Objective: Evidence on long-term costs of atrial fibrillation (AF) and associated factors is scarce. As part of the Swiss-AF prospective cohort study, we aimed to characterise AF costs and their...
8.
Girod M, Coslovsky M, Aeschbacher S, Sticherling C, Reichlin T, Roten L, et al.
Clin Res Cardiol
. 2022 Apr;
111(9):1048-1056.
PMID: 35403852
Background: Patients with atrial fibrillation (AF) face an increased risk of adverse cardiovascular events. Evidence suggests that early rhythm control including AF ablation may reduce this risk. Methods: To compare...
9.
Brus J, Aebersold H, Grueschow M, Polania R
Nat Commun
. 2021 Dec;
12(1):7337.
PMID: 34921144
Confidence, the subjective estimate of decision quality, is a cognitive process necessary for learning from mistakes and guiding future actions. The origins of confidence judgments resulting from economic decisions remain...